According to BioMarin's SEC filing, the layoffs are a part of a "organisational redesign" that includes steps to halt the development of a gene treatment for hypertrophic cardiomyopathy and cost reductions for the haemophilia medicine Roctavian
Read More
Report further stated that several engineering roles and other services teams, such as the one that operates Apple News, are among the ones being laid off
Read More
